Executive cognition · Decision intelligence

Research for better decisions.

ZENOASIS is the public research and education platform for the SATA-CODA™ ecosystem—helping leaders understand their current operating state before the next consequential decision.

20Research articles
≈5 minFree self-assessment
1 pathAssess → understand → activate

The operating problem

Performance can look intact while decision quality is under strain.

Executive overload often appears as delayed decisions, fractured attention, inconsistent follow-through, and difficulty separating signal from noise. ZENOASIS provides the research context; the assessment provides a self-reported snapshot; SATA-CODA™ provides the structured practice.

A simple human journey

Assess first. Activate second.

Read and recognize

Use the Research Library to understand decision fatigue, cognitive load, attention residue, recovery, and readiness.

Complete the free snapshot

Answer a short set of questions and receive an educational Decision Readiness profile based on your submitted responses.

Choose the deeper protocol

The report presents one commercial recommendation: the SATA-CODA™ 77-Day Immersive Protocol.

One ecosystem · Distinct roles

Trust, transformation, deployment, and ritual.

01

ZENOASIS

Research, public education, and the free assessment pathway.

02

SATA-CODA™

The core human product family and 77-Day Immersive Protocol.

03

ZEN-TECH

The future enterprise deployment, integration, and API layer.

04

DUME

The 11-day inner/outer beauty activation and Day 77 reward layer.

Current product truth

One free assessment. One primary protocol.

The live assessment is a structured self-assessment—not a medical diagnosis or biometric test. The 118 BPM pacing is a proprietary creative and experiential design choice. Individual experiences vary.

Assessment + educational report: freeOptional 77-Day Protocol: $777

Your next decision begins with your current state

Take the free Decision Readiness Assessment.

Receive an educational profile, one immediate recommendation, and a clear explanation of the 77-Day pathway.